Fig. 4: Multilateral treatment strategy based on EGFR signaling and cancer metabolism to stop the progression of HNC.

From various resistance mechanisms against EGFR-targeted therapy and energy metabolism reprogramming in EGFR-centered HNC undergoing progression, the targeting of both EGFR central signaling and metabolism may be a rational treatment strategy